- Research works
- 30 ▼ 52% vs 2013–17
- Citations
- 1k 33.6 per fractional work
- Top-10% rate
- 24.6% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: HRA Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 26.1×. Every wedge is a field page.
Which keywords describe research at HRA Pharma (France)?
By fractional works in all years, weighted toward what it does more of than the world: Family Planning, Reproductive Health, Contraception, Unintended Pregnancy, Fertility, Immunosuppressive Drugs, Metabolic Syndrome and Maternal Mortality.
- Taxanes
- Nuclear Receptors
- Inflammation
- Chemotherapy-Induced Peripheral Neuropathy
- Sexually Transmitted Infections
- Polycystic Ovary Syndrome
- Neurotoxicity
- HIV Transmission
- Breast Cancer
- Obesity
- Teratogenicity
- Oxidative Stress
- Inflammatory Bowel Disease
- Maternal Mortality
- Immunosuppressive Drugs
- Unintended Pregnancy
- Reproductive Health
- Family Planning
- Contraception
- Fertility
- Metabolic Syndrome
- Corticosteroid Therapy
- Medication Use
- Pregnancy
- Quality of Life
- Cardiovascular Disease
- Child Mortality
- Health Systems
- Ovarian Reserve
- Risk Factors
- Vaginal Microbiome
- Hiccups
- Neurological Disorders
- Pharmacological Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Family Planning6▲ 380×2 topics
- Reproductive Health6▲ 455×2 topics
- Contraception6▲ 753×1 topic
- Unintended Pregnancy6▲ 753×1 topic
- Fertility3▲ 107×2 topics
- Immunosuppressive Drugs2▲ 104×2 topics
- Metabolic Syndrome2▲ 7.6×4 topics
- Maternal Mortality2▲ 34×2 topics
- Corticosteroid Therapy2▲ 213×2 topics
- Inflammatory Bowel Disease2▲ 52×1 topic
- Medication Use2▲ 247×1 topic
- Oxidative Stress2▲ 3.1×8 topics
- Pregnancy2▲ 26×2 topics
- Teratogenicity2▲ 84×2 topics
- Quality of Life2▲ 3.6×3 topics
- Obesity1▲ 6.1×3 topics
- Cardiovascular Disease1▲ 4.0×5 topics
- Breast Cancer1▲ 14×4 topics
- Child Mortality1▲ 67×1 topic
- HIV Transmission1▲ 43×2 topics
- Health Systems1▲ 67×1 topic
- Neurotoxicity1▲ 20×2 topics
- Ovarian Reserve1▲ 87×1 topic
- Polycystic Ovary Syndrome1▲ 87×1 topic
- Risk Factors1▲ 3.3×3 topics
- Sexually Transmitted Infections1▲ 62×1 topic
- Vaginal Microbiome1▲ 116×1 topic
- Chemotherapy-Induced Peripheral Neuropathy1▲ 66×1 topic
- Hiccups1▲ 740×1 topic
- Inflammation1▲ 1.45×9 topics
- Neurological Disorders1▲ 5.1×2 topics
- Nuclear Receptors1▲ 19×2 topics
- Pharmacological Treatment1▲ 740×1 topic
- Taxanes1▲ 66×1 topic
Which research topics does HRA Pharma (France) publish most on?
By volume in 2022–2025: Reproductive Health and Contraception, Pregnancy and Medication Impact, Food composition and properties and Lymphoma Diagnosis and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Reproductive Health and Contraception Public Health, Environmental and Occupational Health 1 works
- 2 Pregnancy and Medication Impact Public Health, Environmental and Occupational Health 1 works
- 3 Food composition and properties Nutrition and Dietetics 0 works
- 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 5 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
- 6 Reproductive tract infections research Microbiology 0 works
- 7 Cancer Cells and Metastasis Oncology 0 works
- 8 Pharmaceutical industry and healthcare Pharmacology 0 works
- 9 Gut microbiota and health Molecular Biology 0 works
- 10 Essential Oils and Antimicrobial Activity Food Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has HRA Pharma (France)'s research output changed?
Output in 2018–2022 was 52% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.